fbpx

Researchers Go Head-to-head Dragon’s Den Style in ‘Eye on the Cure’ Research Award Competition

For the second year in a row, three teams of Canadian researchers working to find treatments for blinding eye diseases are vying for three coveted prizes at Fighting Blindness Canada’s (FBC) Eye on the Cure awards competition, presented by FYidoctors. The competition, moderated by health journalist and former CTV Medical Correspondent Avis Favaro, has teams going head-to-head Dragon’s Den-style in front of three judges and members of the Academy, with $100,000 up for grabs to advance vision research.

“Now more than ever, it is so important to encourage and invest in the research of tomorrow,” said Dr. Larissa Moniz, Director of Research and Mission Programs at Fighting Blindness Canada (FBC). “We are so excited to have the opportunity to spotlight and support these talented researchers as they work to develop new diagnostics and treatments for vision loss.”

Expert judges and an Academy made up of FBC’s biggest supporters will vote for the winners of the $50,000 FYidoctors Research to Watch Award. However, anyone can cast a vote for the winner of the $30,000 Heathbridge Capital People’s Choice Award with a $50 minimum donation.

This year’s researcher finalists include:

  • Dr Bob Chow & Dr. Bridget Ryan, focusing on Stargardt disease
  • Dr. Anna Ells & Dr. Ellen Zhou, focusing on retinopathy of prematurity
  • Dr. Patrick Gooi & Dr. Abdullah Al-Ani, focusing on glaucoma

Eye on the Cure will be streamed at fightingblindness.ca/FBCeyeonthecure on November 18th at 12 p.m. EST. Voting closes November 19th at 11:59 p.m. EST. The award winners will be announced on FBC’s Facebook channel, live November 22nd at 12 p.m. EST.

“Eye on the Cure gives all Canadians a one-of-a-kind opportunity to make a real impact on the future of vision science and secure the research aspirations of these teams,” Moniz added. “It’s an opportunity to have a say in something that is life-changing.”

To watch Eye on the Cure for free or place a donation to vote, register at fightingblindness.ca/fbceyeonthecure

Source: Fighting Blindness Canada

Featured Posts

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Learn More

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Read more

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Learn More

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read More

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read More

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Read More

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read More

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Learn More

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Read more

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Learn More

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

LE PARC: Discover the New Fall/Winter Collection 2023

Inspired by art, culture and creative freedom, LE PARC designs vibrant and sophisticated eyewear that highlights the identity of each individual.

Read more

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa.

Read more